Buy Semaglutide Online — 5 sizes (3 mg–30 mg)
Metabolic-rate investigations focused on incretin receptor pharmacology.
Semaglutide is a long-acting GLP-1 receptor agonist that has become one of the most discussed compounds in incretin biology. In research settings, it is used to study energy balance, gastric emptying, and the central-nervous-system effects of GLP-1 pathway activation.
Vial sizes and price per mg
Up to 50% cheaper per mgReconstitution volumes
Volumes of bacteriostatic water required to dissolve each vial at common research concentrations.
| Vial | at 2 mg/mL | at 5 mg/mL | at 10 mg/mL |
|---|---|---|---|
| 3 mg | 1.50 mL | 0.60 mL | 0.30 mL |
| 6 mg | 3 mL | 1.20 mL | 0.60 mL |
| 12 mg | 6 mL | 2.40 mL | 1.20 mL |
| 20 mg | 10 mL | 4 mL | 2 mL |
| 30 mg | 15 mL | 6 mL | 3 mL |
Numbers are calculated from the stated vial mass. Verify against the supplier's instructions for your specific research protocol.
Mechanism in the literature
GLP-1 receptor agonism increases glucose-dependent insulin secretion, slows gastric emptying, and acts centrally on appetite-regulating nuclei in the hypothalamus. Semaglutide is engineered with a fatty-acid side chain that extends its half-life to roughly one week in animal studies.
Research use-cases
- GLP-1 analog with extended half-life (~7 days in research)
- Featured across metabolic, cardiovascular, and neurological research models
- Slower titration schedules are used in protocols to manage known GI-tolerance endpoints
- Benchmarked in the literature against tirzepatide, retatrutide, and cagrilintide
Often paired with
Buyers viewing Semaglutide typically also consider Cagrilintide, AOD9604 and L-Carnitine 5-Pack. Each is in stock, sealed under nitrogen with a lot-matched CoA.
Handling in the lab
Most research protocols reconstitute semaglutide in bacteriostatic water and administer once weekly. Titration schedules that begin at a low concentration and scale over several weeks are common to study tolerability endpoints.
Stacking and paired-compound work
Cagri-sema (cagrilintide + semaglutide) is a frequently studied dual-incretin/amylin combination. Tirzepatide and retatrutide are distinct compounds often compared against semaglutide in head-to-head metabolic research.
Frequently asked
Is semaglutide the same as Ozempic or Wegovy?
Those are commercial pharmaceutical formulations of semaglutide. Research-grade material sold here is for laboratory use only and is not a substitute for a prescribed product.
What is the difference between semaglutide and tirzepatide in research?
Semaglutide is a GLP-1 agonist. Tirzepatide is a dual GIP/GLP-1 agonist — it activates two incretin receptors. Retatrutide adds a glucagon receptor, making it a triple agonist.
Why does it come in multiple vial sizes?
Research protocols vary widely in concentration and duration. Larger vials (20–30 mg) reduce per-mg cost for long-running studies; smaller vials are used for short pilots.
Is a COA provided?
Yes — each lot is independently tested. Request the matching document from the supplier.
More Fat Loss compounds
-10%
3 sizes-10%
-10%
2 sizes-10%